PF-04802367 is a GSK-3 ligand that binds the kinase catalytic region and provides a recognition scaffold for degradation-oriented studies of glycogen synthase kinase signaling. As a selective kinase inhibitor-derived ligand, it may be adapted for PROTAC design when a suitable attachment site preserves GSK-3 engagement. In a bifunctional degrader, the PF-04802367-derived moiety would bind GSK-3, while a linker connects it to an E3 ligase recruiter to bring the kinase into proximity with ubiquitination machinery. The intended mechanism is GSK-3 ubiquitination and proteasome-dependent depletion, enabling analysis of protein-level loss beyond catalytic inhibition. PF-04802367 is useful for Wnt and metabolic signaling research, kinase degrader exploration, target engagement assays, linker-vector assessment, and comparison of inhibitor-based versus degradation-based modulation of GSK-3 biology.
Structure of 1962178-27-3
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Target: This ligand targets glycogen synthase kinase 3 alpha and beta (GSK3α/GSK3β) in biochemical or cellular target-engagement studies.
Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for glycogen synthase kinase 3 alpha and beta (GSK3α/GSK3β). In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings glycogen synthase kinase 3 alpha into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.
Applications• PROTAC-Mediated Target Degradation: PF-04802367 can be used as a ligand component in PROTAC designs to recruit an E3 ligase and drive ubiquitination of the associated target protein. This enables systematic evaluation of degradation potency, selectivity, and kinetics across engineered PROTAC architectures and linker lengths in cellular protein turnover assays.
• E3 Ligase Recruitment Optimization: Incorporating PF-04802367 into PROTAC constructs supports mapping of how ligand orientation and conjugation chemistry influence productive ternary complex formation. Researchers can compare degradation outcomes across different E3 ligase recruiters and attachment sites, using proteomics and time-course Western blotting to identify configurations that maximize target engagement and turnover.
• Ternary Complex Mechanism Studies: PF-04802367-based PROTACs are suitable for mechanistic studies of cooperative binding and ternary complex stabilization. By quantifying binding relationships and degradation efficiency under varying concentrations, investigators can infer whether enhanced degradation arises from improved complex formation, altered residence time, or changes in ubiquitin transfer efficiency.
• Structure–Activity Relationship Probing: PF-04802367 can serve as a starting ligand for SAR campaigns that tune PROTAC properties such as linker length, rigidity, and steric bulk. These experiments help determine how physicochemical and spatial parameters affect ubiquitination, endosomal trafficking dependence, and the balance between degradation and residual inhibition in target protein assays.
PF-04802367 is a kinase-ligand scaffold with polar side-chain functionality suitable for linker-vector exploration. It may be used for PROTAC design after target engagement and exit-vector tolerance are confirmed.
Structure: PF-04802367 is a kinase-ligand scaffold containing chlorinated aryl substitution, a heteroaryl carboxamide region, and a morpholine-containing polar side chain. The structure includes ring nitrogens, an amide carbonyl, and a basic cyclic ether/amine motif that may affect solubility and linker-vector selection.
Reactivity: PROTAC design with PF-04802367 should preserve the kinase-recognition heteroaryl and amide features. The morpholine-containing side chain or peripheral aryl region is a more appropriate linker-vector candidate than the central binding core. Alkyl, PEG, amide, carbamate, or tertiary-amine-compatible linkers can be connected to CRBN, VHL, or IAP ligands after confirming that analog derivatization retains target engagement.
can PF-04802367 be used in vitro?
Yes, PF-04802367 can be used in vitro. Yes, PF-04802367 can be used in vitro. It is a small molecule with a molecular weight of 361.78 g/mol. It has a melting point of 117-119 °C and a boiling point of 275-277 °C. It is a solid at room temperature and is stable in air and at room temperature. PF-04802367 is a potent inhibitor of glycogen synthase kinase 3 (GSK-3). GSK-3 is an enzyme that plays a role in cell signaling and metabolism. The inhibition of GSK-3 has been shown to have anti-diabetic, anti-aging, and anti-cancer effects. PF-04802367 has been shown to be effective in vitro in a number of assays, including: Inhibition of GSK-3 activity Modulation of tau phosphorylation Reduction of amyloid-beta production Protection of neurons from damage PF-04802367 is currently in clinical trials for the treatment of Alzheimer's disease.
3/12/2017
what is the functional group of PF-04802367?
PF-04802367 has the following functional groups: A pyridine carboxamide group: This is a functional group that consists of a nitrogen atom that is bonded to a pyridine ring and a carboxylic acid group. The pyridine carboxamide functional group in PF-04802367 is responsible for its biological activity. A 4-fluorophenyl group: This is a functional group that consists of a fluorine atom that is bonded to a phenyl ring. The 4-fluorophenyl group in PF-04802367 contributes to its solubility in organic solvents. A methoxy group: This is a functional group that consists of a carbon atom that is bonded to an oxygen atom and a hydrogen atom. The methoxy group in PF-04802367 contributes to its solubility in water. The functional groups in PF-04802367 are responsible for its properties, including its biological activity, solubility, and stability.
5/4/2019
can PF-04802367 be used in vitro?
Yes, PF-04802367 can be used in vitro.The stability of PF-04802367 in vitro has been studied in a number of studies. In one study, PF-04802367 was stored at 37°C for up to 1 week and no significant degradation was observed. In another study, PF-04802367 was stored at 4°C for up to 3 months and no significant degradation was observed.
27/2/2022
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.